Thousands of patients in California and across the nation who take expensive every month for , and other ailments are facing sticker shock at the pharmacy.
Until recently, most of these patients typically paid modest co-pays for the advanced drugs. But increasingly, Anthem Blue Cross, and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost.
Read the full story: http://hcp.lv/KXEKBf
Source: Los Angeles Times